A.M. Best Affirms Aetna's Ratings - Analyst Blog

By Zacks.com June 29, 2012, 01:11:24 PM EDT

As a part of its yearly review process, the rating agency A.M. Best affirmed its issuer credit ratings ("ICR") of 'bbb+' for health insurer Aetna Inc. ( AET ). The ratings of all of its subsidiaries were reviewed as well. The revision resulted in affirmation of financial strength rating ("FSR") of 'A' and an ICR of 'a+' for 16 of its subsidiaries. An FSR of 'A' and ICR of 'a' were affirmed on Aetna Insurance Company of Connecticut, Continental Life Insurance Company of Brentwood and American Continental Insurance Company. The ratings are of investment grade and carry a stable outlook. 

A.M. Best's rating affirmation of Aetna's chief operating subsidiary Aetna Life Insurance Company ("ALIC") and its insurance and Health Maintenance Organization acknowledges their strong operational and financial performance over the recent years. The earnings of these units have benefited from lower-than-average utilization by members. But the rating agency also cautions that the trend may not continue for long and that utilization levels may revert to normal levels soon. This may adversely affect bottom line earnings. Another concern for the rating agency is that ALIC's medical cost ratio has increased in the recently reported earnings and its membership may suffer in the near term given an uncertain and competitive market environment.

A.M. Best views Aetna's strong financial position favorably.  As of March 31, the company had a debt-to-total capitalization ratio of approximately 29%. A.M. Best expects that the company's leverage ratio may go northwards in case the company makes acquisitions and raises debt for funding purpose. The rating agency expects the company to maintain a leverage ratio of around 30%. It continues to target a risk-based capital ratio of approximately 300%. The capital level at the holding company is fully cushioned with subsidiary dividends of approximately $1.7 billion expected for the full year 2012.

The rating agency is also concerned about a decline in membership enrollment witnessed during the recent earnings release. At the end of the first quarter, Aetna had 17.9 million medical members, a decline of 544,000 members from year end 2011.

The rating agency has a favorable view of Aetna's growth momentum in the Medicare business where significant growth is expected over the coming years. The company has made a number of acquisitions to expand its Medicare line of business and this positions it well for long-term growth.  Though the company has made significant efforts to secure contracts for the National Accounts business, it has had its share of setbacks. Recently the company lost its Ohio contract to Centene. The pressure on Government business will, however, not have an adverse effect on earnings since it forms a very small part of the company's business.

Though unlikely, the possibility of a negative rating action cannot be ruled out if Aetna's operating profitability and risk-based capital ratio decline significantly. A high leverage ratio can also increase the chances of a rating downgrade. 

Financial strength and credit ratings, which are intended to measure a company's ability to meet policyholder obligations, are important factors affecting public confidence, and hence a company's competitiveness. Securing an investment grade debt rating with a stable outlook reflects optimism about Aetna's future performance.

Aetna also scores strongly with other rating agencies. In April, Standard and Poor's raised the financial strength ratings of the company's subsidiaries by one notch to 'A+' from 'A' while affirming the A-/A-2 counterparty credit rating on the parent company. All these ratings are of investment grade and carry a positive outlook.

Peer CIGNA Corp. ( CI ) also carries an ICR of 'bbb' and a financial strength rating of 'A', with a stable outlook from A.M. Best.

Aetna currently retains a Zacks # 3 Rank, which translates into a short-term 'Hold' rating. Considering its better-than-average fundamentals, we are maintaining our long-term "Outperform" recommendation on the shares.


 
AETNA INC-NEW (AET): Free Stock Analysis Report
 
CIGNA CORP (CI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Business, Stocks

Referenced Stocks: AET, CI



Latest News Video



From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.44 0.07  0.52%
F $ 14.95 0.10  0.66%
CLWR $ 3.40 0.14  4.29%
SIRI $ 3.515 0.02  0.43%
MSFT $ 34.85 0.23  0.66%
CSCO $ 24.01 0.07  0.27%
MRK $ 47.33 2.12  4.69%
PFE $ 28.78 0.08  0.28%